化合物 Metallo-β-lactamase-IN-6 T60239
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 1439899-44-1 | ¥13,800.00 | 询底价 |
100 mg | 1439899-44-1 | ¥17,500.00 | 询底价 |
25 mg | 1439899-44-1 | ¥10,600.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Metallo-β-lactamase-IN-6
描述: Metallo-β-lactamase-IN-6 is a highly effective inhibitor of VIM-Type metallo-β-lactamase, demonstrating IC 50 values of 0.56 μM, 29.50 μM, and 5.78 μM for VIM-2, VIM-1, and VIM-5, respectively. In addition, Metallo-β-lactamase-IN-6 exhibits potent synergistic antibacterial properties when combined with Meropenem, particularly against engineered Escherichia coli strains and clinically isolated Pseudomonas aeruginosa carrying the VIM-2 MBL gene [1].
体外活性: Metallo-β-lactamase-IN-6 (compound 55) (10 μM; 18 - 20 hours) can potentiate the activity of Meropenem against VIM-2 mediated antibacterial resistance with FIC index values of 0.05 [1]. Metallo-β-lactamase-IN-6 (1, 10, 100 μM; 18 - 20 hours) can penetrate E. coli outer membrane and restore Meropenem activity against PBP3 by blocking destructive effect of VIM-2 enzyme to Meropenem [1]. Metallo-β-lactamase-IN-6 (100 μM) potentiates the antibacterial activity of Meropenem against PA W35 with FIC index values of 0.25 [1].
体内活性: Metallo-β-lactamase-IN-6 (100 mg/kg; IP; single) reaches plasma concentration peak approximately 9 min after injection with an effective maximum concentration of 142.8 μg/ml and the T 1/2 of 1.24 hours [1]. Metallo-β-lactamase-IN-6 (500, 1000, or 2000 mg/kg; IP; single, observe for 14 days) does not result in any significant toxic effects and is well-tolerated by mice at a dose of ≤ 2000 mg/kg [1]. Pharmacokinetic Parameters of Metallo-β-lactamase-IN-6 in male female ICR mice [1]. IP (100 mg/kg) T 1/2 (h) 1.243 C max (μg/mL) 142.8 T max (h) 0.151 Vd (mL/kg) 535.804 CL (mL/h/kg) 248.512 AUC 0-∞ (μg/mL·h) 896 Animal Model: Female ICR mice (180-220 g) [1] Dosage: 100 mg/kg Administration: IP; single (Pharmacokinetics Analysis) Result: Plasma concentration reached its peak about 9 min after injection with an effective maximum concentration of 142.8 μg/ml, and the T 1/2 was 1.24 hours. Animal Model: Female ICR mice (n=5) [1] Dosage: 500, 1000, or 2000 mg/kg Administration: IP; single, observed for 14 days Result: Did not result in any significant toxic effects and was well-tolerated by mice at a dose of ≤ 2000 mg/kg.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
化合物 Metallo-β-lactamase-IN-6 T60239信息由TargetMol中国为您提供,如您想了解更多关于化合物 Metallo-β-lactamase-IN-6 T60239报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途